1. Home
  2. SMID vs ACTU Comparison

SMID vs ACTU Comparison

Compare SMID & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • ACTU
  • Stock Information
  • Founded
  • SMID 1960
  • ACTU 2015
  • Country
  • SMID United States
  • ACTU United States
  • Employees
  • SMID N/A
  • ACTU N/A
  • Industry
  • SMID Building Materials
  • ACTU
  • Sector
  • SMID Industrials
  • ACTU
  • Exchange
  • SMID Nasdaq
  • ACTU NYSE
  • Market Cap
  • SMID 166.5M
  • ACTU 153.1M
  • IPO Year
  • SMID 1995
  • ACTU 2024
  • Fundamental
  • Price
  • SMID $37.36
  • ACTU $8.55
  • Analyst Decision
  • SMID
  • ACTU
  • Analyst Count
  • SMID 0
  • ACTU 0
  • Target Price
  • SMID N/A
  • ACTU N/A
  • AVG Volume (30 Days)
  • SMID 16.3K
  • ACTU 48.7K
  • Earning Date
  • SMID 11-19-2024
  • ACTU 11-21-2024
  • Dividend Yield
  • SMID N/A
  • ACTU N/A
  • EPS Growth
  • SMID N/A
  • ACTU N/A
  • EPS
  • SMID 0.87
  • ACTU N/A
  • Revenue
  • SMID $68,434,000.00
  • ACTU N/A
  • Revenue This Year
  • SMID N/A
  • ACTU N/A
  • Revenue Next Year
  • SMID N/A
  • ACTU N/A
  • P/E Ratio
  • SMID $41.82
  • ACTU N/A
  • Revenue Growth
  • SMID 26.77
  • ACTU N/A
  • 52 Week Low
  • SMID $21.28
  • ACTU $5.51
  • 52 Week High
  • SMID $48.87
  • ACTU $10.16
  • Technical
  • Relative Strength Index (RSI)
  • SMID 66.01
  • ACTU N/A
  • Support Level
  • SMID $32.31
  • ACTU N/A
  • Resistance Level
  • SMID $35.00
  • ACTU N/A
  • Average True Range (ATR)
  • SMID 1.40
  • ACTU 0.00
  • MACD
  • SMID 0.45
  • ACTU 0.00
  • Stochastic Oscillator
  • SMID 94.40
  • ACTU 0.00

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Share on Social Networks: